- In February 2025, Thermo Fisher Scientific agreed to acquire Solventum’s purification and filtration business for approximately $4.1 billion in cash. This acquisition aligns with Solventum's strategy to refine its portfolio by divesting segments that do not fit its core focus areas like wound care, oral care, healthcare IT, and biopharma filtration. The filtration unit generated about $1 billion in revenue in 2023.
- In July 2024, IDEX Corporation announced its plan to acquire Mott Corporation, a filtration products maker, for $1 billion in cash. Mott specializes in machinery and devices used in industries such as pharmaceuticals, biotechnology, and chemical manufacturing. The acquisition aims to bolster IDEX's presence in the medical technologies industry and is expected to close by the end of Q3 2024.
- In January 2023, Hollingsworth & Vose announced a $40.2 million investment to expand its manufacturing facility in Floyd, Virginia. The expansion will add over 28,000 square feet to accommodate new production equipment, supporting the company's Trupor business, which focuses on high-performance liquid microfiltration media
- In January 2023, Koch Separation Solutions (KSS) partnered with Aqana to offer anaerobic wastewater treatment technology to industrial customers in North America. The collaboration focuses on integrating technologies such as moving bed biofilm reactors (MBBR), membrane bioreactors (MBR), and reverse osmosis (RO) to address various industrial wastewater treatment challenges.
- In October 2024, Veralto, a company spun off from Danaher, increased its annual adjusted profit forecast for the third time that year due to ongoing high demand for its water treatment products, including chemical treatment services and UV-filtration systems. The company's net sales for the third quarter rose by 4.7% to $1.31 billion
